Company / Book Value per Share
Biogen Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$125.996
FY2025
5-year range
$62.55 / $125.996
FY2021-FY2025
Trend
+8.5%
vs FY2024
Sector context
#6 of 211
Health Care
What the data says
Among 211 Health Care companies, Biogen is in the top 3% for book value per share. Book Value per Share has increased for 5 consecutive years, from $54.261 in FY2020 to $125.996 in FY2025.
Based on SEC 10-K filings.
$125.996 in FY2025 with a 5-year CAGR of +18.4%. Top quartile in the Health Care sector.
Improved from $100.676 to $125.996 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +12.7%
- 5-Year CAGR
- +18.4%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 211This company $125.996 Sector average $213.854
▼
-41.1% below sector average
Key checks
Key Insights
- Biogen's book value per share has grown for 5 consecutive years.
- 5-year CAGR of +18.4%, indicating consistent growth.
- In FY2025, book value per share increased 8.5% year-over-year.
- Ranks #6 out of 211 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $125.996 | +8.5% |
| FY2024 | $116.083 | +15.3% |
| FY2023 | $100.676 | +14.5% |
| FY2022 | $87.913 | +40.5% |
| FY2021 | $62.55 | +15.3% |
| FY2020 | $54.261 | -14.0% |
| FY2019 | $63.088 | +4.5% |
| FY2018 | $60.396 | +3.4% |
| FY2017 | $58.42 | +5.2% |
| FY2016 | $55.536 | +39.0% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026